After being seeded by INVENT Ventures and Heliant Ventures, Sanguine BioSciences is on a mission to “enhance the quality and availability of biospecimen, and ultimately provide researchers with the high quality samples needed for basic research as well as drug and biomarker discovery,” according to its website. The Valencia, CA-based company engages research subjects through social media and non-profit advocacy, and schedules biomedical research procedures. The company’s platform is also designed to keep research participants informed of how their samples are used. Proceeds from the seed round will help further develop the company’s internal infrastructure so it can scale up and continue operations.
